World Trade Center Health Program Mentored Research Scientist Career Development Award (K01)

World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) is sponsored by Centers for Disease Control and Prevention (CDC). This K01 award supports mentored research career development related to the World Trade Center Health Program.

Expired RFA-OH-24-004: World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) This notice has expired. For NIH, in limited situations, applications may be accepted on a case-by-case basis for a short period after expiration to accommodate NIH late or continuous submission policies . Contact the eRA Service Desk for any submission issues.

Check the NIH Guide for active opportunities and notices. Department of Health and Human Services Part 1.

Overview Information Participating Organization(s) Centers for Disease Control and Prevention ( CDC ) The policies, guidelines, terms, and conditions of the HHS Centers for Disease Control and Prevention (CDC) stated in this notice of funding opportunity (NOFO) might differ from those used by the HHS National Institutes of Health (NIH).

If written guidance for completing this application is not available on the CDC website, then CDC will direct applicants elsewhere for that information.

of Participating Organizations National Institute for Occupational Safety and Health ( NIOSH ) Funding Opportunity Title World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) Research Scientist Development Award - Research & Training March 31, 2025 - This funding opportunity was updated to align with agency priorities.

Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. April 04, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084 February 22, 2024 - Extension of Application Receipt Dates for RFA-OH-24-004 World Trade Center Health Program Mentored Research Scientist Career Development Award (K01).

See Notice NOT-OH-24-010 Notice of Funding Opportunity (NOFO) Number Companion Notice of Funding Opportunity Eligible applicant institutions may submit more than one application, provided that each application is scientifically distinct. See Section III. 3.

Additional Information on Assistance Listing Number(s) Funding Opportunity Purpose The purpose of the National Institute for Occupational Safety and Health (NIOSH) and World Trade Center (WTC) Health Program Mentored Research Scientist Career Development Award (K01) is to provide support and 75% protected time (up to 3 years) for an intensive, supervised (mentored) career development experience in WTC-related health research.

This can facilitate the transition of junior research scientists from the mentored to the independent stages of their careers in WTC-related health research.

By providing support for the critical transition period between postdoctoral training and independent U01 or R01 funding for investigators, NIOSH/WTC Health Program hopes to foster the careers of these investigators, who are vital for the future excellence of WTC-related health research endeavors.

Applicants must justify the need for a period of mentored research experience and convincingly describe how the proposed period of support will substantially enhance their careers as independent investigators. Applicants must also concisely describe the issues related to diagnostic or treatment uncertainty addressed in their proposal.

Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

The NIOSH/WTC Health Program supports K01 grants to help ensure the availability of an adequate number and diversity of highly trained scientists and educators to address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B of the James Zadroga 9/11 Health and Compensation Act of Law 111 347 , as amended by Public Laws 114 113 , WTC responders, screening-eligible WTC survivors, and certified-eligible WTC survivors comprise the population targeted for the research project.

Research funded by the WTC Health Program is primarily intended for the benefit of the 9/11-exposed population. It is not required that project findings be generalizable to other populations.

NIOSH is soliciting Mentored Research Scientist Career Development research projects within the following six major areas of clinical research interest: Implementation Research, Health Services Research, Health Equity Research, Treatment Research, Prevention Research, and Quality of Life Research. The WTC Health Program Research webpage provides comprehensive information and tools for researchers.

The research agenda, publication library, and other resources, including the Funding Dashboard, can also be found there (e.g., awarded project details such as publications, topics, populations, funding awarded, and the principal investigators and their institutions).

Open Date (Earliest Submission Date) Letter of Intent Due Date(s) November 1, 2023; September 27, 2024; September 26, 2025 (LOI recommended but not required) December 5, 2023; October 29, 2024; October 28, 2025 On-time submission requires that electronic applications be error-free and made available to CDC for processing from the NIH eRA system on or before the deadline date.

Applications must be submitted to and validated successfully by Grants. gov no later than 5:00 PM U.S. Eastern Time on the listed application Applicants will use a system or platform to submit their applications through Grants. gov and eRA Commons to CDC.

ASSIST, an institutional system to system (S2S) solution, or Grants. gov Workspace are options. ASSIST is a commonly-used platform because it provides a validation of all requirements prior to submission and prevents errors.

For more information on accessing or using ASSIST, you can refer to the ASSIST Online Help Site at: https://era. nih. gov/erahelp/assist .

Additional support is available from the NIH eRA Service Desk via https://www. era. nih.

gov/need-help . E-mail: [email protected] Phone: 301-402-7469 or (toll-free) 1-866-504-9552 Hours: Monday - Friday, 7 a. m.

to 8 p. m. Eastern Time, excluding Federal holidays Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission HHS/CDC grant submission procedures do not provide a period beyond the application due date time to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.

gov or eRA systems (i.e., error correction window). AIDS Application Due Date(s) March 2024; March 2025; March 2026 New Date October 29, 2025 per issuance of NOT-OH-24-010 . (Original Expiration Date: It is critical that applicants follow the Career Development (K) Instructions in the How to Apply - Application Guide , except where instructed to do otherwise in this NOFO.

Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV . When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

do not comply with these instructions may be delayed or not accepted for review. Telecommunications for the Hearing Impaired: TTY 1-888-232-6348. Part 1.

Overview Information Part 2. Full Text of the Announcement I. Notice of Funding Opportunity Description Section II.

Award Information Section III. Eligibility Information Section IV. Application and Submission Information Section V.

Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII.

Other Information Part 2. Full Text of Announcement Section I. Notice of Funding Opportunity Description The World Trade Center Health Program is authorized under Section 301 of the Public Health Service Act as amended (42 U.S.C.

241) and the James Zadroga 9/11 Health and Compensation Act of 2010 ( Public Law 111 347 , as amended by Public Laws 114 113 , codified in Title XXXIII of the Public Health Service Act at 42 U.S.C. 300mm 300mm 62. The authority for this specific research is found in Section 3341 of the Zadroga Act, as amended (42 U.S.C.

300mm 51). The World Trade Center (WTC) Health Program is administered by the National Institute for Occupational Safety and Health (NIOSH). Program information is available at the WTC Health Program website .

The James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111 347 (hereafter referred to as the Zadroga Act ) was signed by President Obama on January 2, 2011, and was re-authorized on December 18, 2015 (the Consolidated Appropriations Act, 2016, Public Law 114 113 ), and further amended by Public Laws 116 59 and The Zadroga Act established monitoring and treatment activities for responders and survivors of the September 11, 2001, terrorist attacks and requires the establishment (under Subtitle C) of a research program on health conditions resulting The Zadroga Act lists the following broad research areas ( 42 Physical and mental health conditions that may be related to the September 11, 2001, terrorist attacks; Diagnosing WTC-related health conditions for which there has been diagnostic uncertainty; and Treating WTC-related health conditions for which there has been Research conducted under the Zadroga Act includes epidemiologic and other research studies on WTC-related health conditions or emerging conditions among (1) WTC responders, screening-eligible WTC survivors, and certified-eligible WTC survivors under treatment and individuals who were exposed within a geographic area related to the September 11, 2001, terrorist attacks in a manner similar to the exposure within such geographic area experienced by individuals meeting the eligibility criteria under section 3311(a)(2) or 3321(a)(1)(B); and (2) sampled populations outside the New York City disaster area in Manhattan as far north as 14th Street and in Brooklyn, along with control populations, to identify potential for long-term adverse health effects in less exposed populations.

The Zadroga Act established the requirement Scientific/Technical Advisory Committee and states that the WTC Program Administrator shall consult with the committee in carrying out research activities related to the September 11, 2001, terrorist attacks.

The purpose of the NIOSH and WTC Health Program Mentored Research Scientist Career Development Award (K01) is to provide support and 75% protected time (up to 3 years) for an intensive, supervised (mentored) career development experience in WTC-related health research. This can facilitate the transition of junior research scientists from the mentored to the independent stages of their careers in WTC-related health research.

By providing support for the critical transition period between postdoctoral training and independent U01 or R01 funding for investigators, NIOSH/WTC Health Program hopes to foster the careers of these investigators, who are vital for the future excellence of WTC-related health research endeavors.

Applicants must justify the need for a period of mentored research experience and convincingly describe how the proposed period of support will substantially enhance their careers as independent investigators. Applicants must also concisely describe the issues related to diagnostic or treatment uncertainty addressed in their proposal.

Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

The NIOSH/WTC Health Program supports K01 grants to help ensure the availability of an adequate number and diversity of highly trained scientists and educators to address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B of the James Zadroga 9/11 Health and Compensation Act of 2010 Law 111 347 , as amended by Public Laws 114 113 , WTC responders, screening-eligible WTC survivors, and certified-eligible WTC survivors comprise the population targeted for the research project.

Research funded by the WTC Health Program is primarily intended for the benefit of the 9/11-exposed population. It is not required that project findings be generalizable to other populations.

areas of research interest NIOSH is soliciting Mentored Research Scientist Career Development research projects (K01) within the following six areas of clinical Research : Projects that study the processes whereby WTC Health Program research outputs are disseminated, adopted, implemented, sustained, and scaled up equitably in real-world settings for affected populations.

Services Research : Projects that examine how people get access to health care and care management services, how much care costs, and what happens to patients as a result of this care. Research projects in this area have the potential to identify improved methods/procedures to organize, manage, finance, and deliver health care.

Health Equity Research : Projects that identify/develop methods to systematically determine whether there are unique vulnerabilities and health disparities among individuals exposed to the 9/11 attacks and aftermath or assess distributions of health outcomes among populations and subgroups.

Vulnerable groups include but are not limited to, women, minorities, foreign-born individuals, and individuals of all ages, with appropriate representation of older adults and individuals exposed to the WTC disaster prior to 18 years Research : Projects that evaluate/identify improved treatment interventions/methods (e.g., medication, psychotherapy, dietary/nutritional, care management and coordination etc.) or promote the development of new or novel treatment approaches, e.g. telemedicine.

Research : Projects that identify/evaluate new methods and interventions (e.g., medicine(s), psychotherapy, vaccines, nutrition, or lifestyle changes) that prevent or mitigate the development or reoccurrence of various diseases/disorders. of Life Research : Projects that identify, develop, or evaluate, methods/interventions that improve comfort and the quality of life for individuals with a chronic illness or multimorbidity.

Relevant focus areas include, but are not limited to: stress management and positive psychology, avoidance of risky substances, and optimization of medication usage and reduction in polypharmacy.

Relevant issues/focus areas related to the following outcomes: Cancer (including prevention/detection/diagnosis of pre-malignant changes) and palliative care, Psychiatric conditions such as post-traumatic stress, anxiety and Cognitive reserve, resilience, or decline, and Equity: Project proposals should include discussions describing how research questions, data collection methods and analysis, and dissemination of results will be inclusive of the diversity in the WTC populations, especially those from historically underrepresented groups including women, minorities, foreign-born individuals, and individuals of all ages, including appropriate representation of older adults and individuals exposed to the WTC disaster prior Applications should clearly state: how the design, content, format and dissemination of outreach efforts will be tailored to the needs of WTC populations from diverse backgrounds; how cultural competence of research and linguistically appropriate dissemination of findings and solutions will be ensured; and how historically underrepresented groups can be included in research projects, e.g., though participation on advisory boards, as researchers/staff, The WTC Health Program Research webpage provides comprehensive information and tools for researchers.

The research agenda, publication library, and other resources, including the Funding Dashboard, can also be found there (e.g., awarded project details such as publications, topics, populations, funding awarded, and the principal investigators and their institutions).

The overall objective of this announcement is to solicit meritorious and scientifically rigorous research applications that will help: improve diagnosis and treatment activities of the WTC Health Program; expand knowledge about health effects related to the September 11, 2001, terrorist attacks; answer critical questions about physical and mental health conditions related to the September 11, 2001, terrorist attacks; and apply lessons learned from 9/11 to improve response to future disasters.

Clinical trials are not required. A candidate may propose 1) to gain research experience in a clinical trial led by a mentor or co-mentor, or 2) to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development.

Researchers are encouraged to review WTC Health Program funded projects and publications by visiting the Program Research webpage to assist with an assessment of research gaps and needs.

Healthy People 2030 and other National Strategic Priorities The WTC research program funded by this NOFO will contribute to the CDC strategic goal, in alignment with an HHS strategic goal and objectives found in Healthy People 2030 , to increase the number of communities that protect and promote health and safety and prevent illness and injury to improve the safety, quality, affordability, and accessibility of health care.

A growing body of evidence suggests that significant health conditions have emerged that are associated with the disaster, particularly for those exposed during the collapse of the towers and those who participated substantially in rescue, recovery, and clean-up operations.

Research to be conducted under the Zadroga Act includes epidemiologic and other research studies on WTC-related health conditions or emerging conditions (1) among enrolled WTC responders and certified-eligible WTC survivors under treatment and individuals who were exposed within a geographic area related to the September 11, 2001, terrorist attacks in a manner similar to the exposure within such geographic area experienced by individuals meeting the eligibility criteria under section 3311(a)(2) or 3321(a)(1)(B); and (2) in sampled populations outside the New York City disaster area in Manhattan as far north as 14th Street and in Brooklyn, along with control populations, to identify potential for long-term adverse health effects in less exposed populations.

Scientific research may inform health care professionals and allow earlier diagnoses of WTC conditions, which may lead to more effective treatment. However, scientifically identifying the causes of health problems or conditions is typically very difficult.

While it is often not possible to determine the specific cause of an individual's illness or condition, it is critical to promote scientifically rigorous studies and reviews of potential health problems or risk factors among the affected population. Research funded by the WTC Health Program is primarily intended for the benefit of the 9/11-exposed population.

It is not required that project findings be generalizable to other populations. The WTC Health Program Research webpage provides comprehensive information and tools for researchers.

The research agenda, publication library, and other resources, including the Funding Dashboard, can also be found there (e.g., awarded project details such as publications, topics, populations, funding awarded, and the principal investigators and their institutions).

Information about current and completed NIOSH-funded research studies pertaining to the World Trade Center can be found on the WTC Health Program Research webpage (including two publications from the WTC Health Program: First Decade of Research and a Workshop on Cognitive Aging and Impairment in the 9/11-Exposed Population).

The WTC Health Registry's reports , prepared for enrollees and the public, include information on its key activities and accomplishments, and details on recent findings about the health consequences of 9/11. Interested applicants are strongly encouraged to visit the WTC Health Program Research webpage for additional information.

The target population for research funded under this NOFO are individuals exposed to the September 11, 2001, terrorist attacks, including responders and community members (also referred to as survivors).

Responder cohorts or populations include: local responders (FDNY and others) who were exposed and (a) still live in the NYC area or (b) have since moved away from the NYC area; and responders who came from outside the NYC area to assist with the response and subsequently returned to their respective home areas.

Screening-eligible and certified-eligible WTC survivors (adults and children) include individuals who lived, worked, went to school, or attended child or adult day care in the New York City (NYC) Disaster Area , CFR 88. 1 , on September 11, 2001, or in the following days, weeks, or months and those otherwise meeting the eligibility criteria in 42 CFR 88.

7 Additionally, proposed research can include sampled populations outside the NYC disaster area in Manhattan as far north as 14th Street and in Brooklyn, along with control populations, to identify potential for long-term adverse health effects in less exposed populations.

Collaboration/Partnerships Interdisciplinary and transdisciplinary collaborations that share expertise are essential to advance WTC Health Program efforts to 1) evaluate linkages between WTC exposures and uncommon health conditions, 2) improve diagnostic and treatment outcomes, and 3) support activities to address emerging WTC Health Program health and well-being priorities.

Studies/Secondary Analysis of Existing Data Applicants considering projects that depend on interaction or collaboration with the Data Centers, or the 9/11 Health Registry associated with the WTC Health Program ( Data Center and WTC Health Registry Contacts , below) must coordinate in advance with the respective Directors or Administrators of the Data Centers to ensure access to data and/or availability of adequate numbers of potential participants are feasible to conduct the proposed research.

Documentation of the study recruitment plan and agreement on this coordination must be included in the application, along with any budgetary needs for the coordination activities, by providing both a letter from the investigator to the Data Center/Health Registry/WTC Health Program and a response letter from the Data Center/Health Registry/WTC Health Program to the investigator.

Data Center and WTC Health Registry Contacts Medical Director Dr. David Prezant, 718-999-2696, [email protected] Administrative Director Ms. Jessica Weakley, 718-999-0412, Associate Director, WTC FDNY Data Center Dr. Rachel Zeig-Owens, 718-403-4416, [email protected] School of Medicine at Mount Sinai Director Dr. Andrew C. Todd, 212-824-7053, [email protected] Data Requests Mr. Christopher R.

Dasaro, 332-323-2806, [email protected] and Hospitals Corporation Medical Director Dr. Joan Reibman, 212-263-6479, [email protected] Executive Director Mr. Scott VanOrden, 646-458-2711, [email protected] Data Center Director Ms. Michelle Hyde, 212-788-0949, [email protected] Public Affairs Manager Paul Gambino, 718-786-4481, [email protected] Evaluation/Performance Measurement Evaluations provide information for management and improve program effectiveness.

The CDC document Framework for Program Evaluation can be helpful. Effective program evaluation is a systematic way to improve and account for public health actions by involving procedures that are useful, feasible, ethical, and accurate.

Understanding and applying the elements of this framework for research projects may enhance planning effective public health strategies, improving existing programs including evidence-based activities, and demonstrating beneficial results and impact of federal funding.

When relevant to the goals of the research project, applicants should describe briefly how the findings may be used to promote, enhance, or advance translation of the research into practice or may be used to inform public health Way Forward: The Translational Impacts of World Trade Center Health Program See Section VIII. Other Information for award authorities and regulations. Section II.

Award Information Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.

Optional: Accepting applications that either propose or do not propose clinical trial(s). Applicants may propose to gain experience in a clinical trial led by a mentor/co-mentor as part of their research career development. help determining whether you are doing a clinical trial?

Funds Available and Anticipated Number of Awards Estimated total funding (direct and indirect) available for this program is expected to be $5. 2M; and assumes a 3-year period of Anticipated number of awards is 6 to 10. Awards issued under this NOFO are contingent on the availability of funds and submission of a sufficient number of meritorious applications.

Award budgets are composed of salary and other program-related expenses, as described below. The total project period may not exceed 3 years. Other Award Budget Information CDC/NIOSH/WTC Health Program will contribute up to $100,000 per year toward the salary and fringe benefits of the career award recipient.

Further guidance on budgeting for career development salaries is provided in the SF424 (R&R) Application Guide. In addition, the candidate may derive additional compensation for effort associated with other Federal sources or awards provided the total salary derived from all Federal sources does not exceed the maximum legislated salary rate and the total percent effort does not exceed 100%. See also NOT-OD-17-094 .

Other Program-Related Expenses CDC/NIOSH/WTC Health Program will contribute up to $60,000 per year toward the research development costs of the award recipient, which must be justified and consistent with the stage of development of the candidate and the proportion of time to be spent in research or career development activities.

These funds may be used for the following expenses: (a) tuition and fees related to career development; (b) research-related expenses, such as supplies, equipment and technical personnel; (c) travel to research meetings or training; and (d) statistical services including personnel Salary for mentors, secretarial and administrative assistants, Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are reimbursed at 8% of modified HHS/CDC grants policies as described in the HHS Grants Policy Statement will apply to the applications submitted and awards made in response to this NOFO.

If you are successful and receive a Notice of Award, in accepting the award, you agree that the award and any activities thereunder are subject to all provisions of 45 CFR Part 75, currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Nonprofits without 501(c)(3) IRS Status (Other than Institutions of For-Profit Organizations (Other than Small Businesses) City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Eligible Agencies of the Federal Government U.S. Territory or Possession Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required.

Attach with "Other Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization.

A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency's existing in-house or contractor resources. FFRDCs enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.

io/cgi-bin/searchECFR . Non-domestic (non-U.S.) Entities (Foreign Institutions) are Non-domestic (non-U.S.) components of U.S. Organizations are not eligible Foreign components, as defined in the HHS Grants Policy Statement , are not allowed. For this announcement, applicants may not include collaborators or consultants from foreign institutions.

All applicable federal laws and policies Applications that exceed the 3-year period of performance limit, the $100,000 limit per year for salary and fringe benefits, $60,000 limit per year for research support, or 8% limit on indirect costs (also known as Facilities & Administrative [F&A] Costs) will be considered non-responsive and will not proceed to peer review.

In these cases, CDC/NIOSH will notify the applicant and request that the application be withdrawn. The Candidate Information and Goals for Career Development and Research Strategy (for both attachments combined) are limited to 12 pages. The page limit includes all text, tables, graphs, figures, diagrams, and charts in this Upon receipt, applications will be evaluated for completeness by NIH/CSR and CDC/NIOSH.

CDC/NIOSH will screen all applications for responsiveness. Incomplete or non-responsive applications will not be reviewed. Applicants will be requested to withdraw non-responsive applications.

Subpopulation(s) under study (see Section I. Target Population for descriptions) or a combination of these populations. If you propose to study a combination of these populations, you must clearly state the percentages of each You must also include the Primary Diseases/Conditions (e.g., respiratory disease , adult mental health , cancer , children’s research or that you propose to study, followed by a brief description.

Subpopulation(s) under study and Primary Diseases/Conditions must be included as one attachment titled " Study Information " in the "12. Other Attachments" section of the "R&R Other Project Information" component of the application.

Please note there are other requirements specific to this announcement that must be included in this section of your application: Evaluation Plan (see Section V, Additional Review Considerations for information), as well as CDC Risk Questionnaire with supporting documentation and Duplication of Efforts (see Section IV, Other Submission Requirements and Information for instructions).

Applicants who plan to collect public health data must Plan (DMP) in the Resource Sharing section of the PHS 398 Career Development Award Supplemental Component of the application. A DMP is required for each collection of public health data proposed. CDC OMB-approved templates may be used (e.g., NCCDPHP template ).

See Section IV, Content and Form of Application Submission and Section V, Additional Review Considerations for information.

The NIOSH Secondary Review Committee (SRC) may categorize and prioritize projects by WTC subpopulation(s) and relevant diseases/conditions based Health Program Reference Documents WTC Health Program Research Publication Library A regularly updated comprehensive listing of 9/11 health research publications from 2001 to present.

Publications can be searched by study population, WTC cohort (responders, survivors, both), year of publication, outcome studied (WTC covered and non-covered conditions), and year published. WTC Research Grant Project Information Dashboard The funding dashboard includes all research projects awarded since 2011 (the year that the Zadroga 9/11 Health and Compensation Act was signed into law).

Project-specific information includes research institution, Principal Investigator, year awarded, and topic area (respiratory disease, mental health, cancer, cardiovascular disease, emerging conditions, and WTC youth).

Interested applicants are strongly encouraged to review the WTC Health Program Research webpage for more Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Unique Entity Identifier (UEI) number in order to begin each of the following registrations.

All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

NOTE: Effective April 4, 2022, applicants must have a Unique Entity Identifier (UEI) at the time of application submission. The UEI replaced the Data Universal Numbering System (DUNS) and is generated as part of SAM. gov registration.

Current SAM. gov registrants have already been assigned their UEI and can view it in SAM. gov and Grants.

gov. Additional information is available website , SAM. gov , and Grants. gov-Finding Award Management (SAM) Applicants must complete and maintain an active registration, at least annually .

The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a